Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?

Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?

Maintenance immunotherapy after concurrent chemoradiotherapy remains the standard therapeutic approach in patients with unresectable locally advanced non-small cell lung cancer (LA-NSCLC). The efficacy of pembrolizumab without chemotherapy in stage IV NSCLC has incited interest in similar approaches...

Full description

Bibliographic Details
Main Authors: Lin Ma, Liufu Deng, Jianfeng Peng, Jinming Yu, Xiangjiao Meng
Format: Article
Language:English
Published: China Anti-Cancer Association 2023-12-01
Series:Cancer Biology & Medicine
Subjects:
locally advanced non-small cell lung cancer (la-nsclc)
radiotherapy
immunotherapy
new regimen
challenges
Online Access:https://www.cancerbiomed.org/content/20/12/1035

Internet

https://www.cancerbiomed.org/content/20/12/1035

Similar Items